Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including APOL1-mediated kidney disease, acute and neuropathic pain, type 1 diabetes and alpha-1 antitrypsin deficiency. Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America.
Vertex Pharmaceuticals
Unlock to Claim this listing
Add / Modify Company
4.41
Overall Excellence Rating
Industry
Gas & Mining, OilCategory
Biotechnology ResearchESG/Ethical Impact
Vertex Pharmaceuticals’ environmental stewardship is palpable through comprehensive strategies encompassing carbon reduction, responsible supply chain practices, sustainable laboratory operations, and eco-friendly manufacturing, underscoring its mission to contribute to a healthier planet while advancing medical advancements and fostering a culture of environmental responsibility that harmonizes seamlessly with its core commitment to improving patients’ lives. An embodiment of positive social impact, Vertex Pharmaceuticals harnesses its biopharmaceutical expertise to uplift patient communities, channeling resources toward addressing unmet medical needs, enhancing patient outcomes, and actively participating in healthcare education, thereby fostering a comprehensive approach to societal well-being that transcends conventional healthcare boundaries and positively influences diverse populations. Vertex’s ESG framework rests on robust governance and ethics that epitomize transparency, integrity, and accountability, permeating decision-making processes through a diverse and experienced board of directors, stringent compliance mechanisms, and ethical conduct that position the company as an exemplar of responsible corporate citizenship and principled leadership within the biopharmaceutical sector. Vertex Pharmaceuticals’ financial sustainability is intrinsically linked with its holistic ESG imperatives, as its financial growth harmoniously aligns with its ability to provide innovative medical solutions that resonate harmoniously with healthcare professionals, patients, and investors who recognize the intrinsic value of responsible innovation and sustainable business practices. Vertex Pharmaceuticals Incorporated, a trailblazer in biopharmaceutical innovation, vividly embodies an unwavering commitment to ESG sustainability that intricately interweaves with its operational fabric, emblematic of its steadfast dedication to ethical integrity, positive societal influence, and enduring value creation. By seamlessly aligning its multifaceted endeavors with the diverse needs of patients, healthcare partners, and global stakeholders, Vertex Pharmaceuticals exemplifies a transformative and conscientious approach to advancing healthcare through sustainable business practices that reverberate harmoniously across the dimensions of medical innovation, patient well-being, and responsible governance.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Awards Received
2023
Revenues
9654000000
Website Traffic
Employee Rating
4.3
Customer Rating
4
Company Size
1000-5000
ESG Risk Rating
3



